Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE ReLife International Medical Center
BEIJING, Oct. 15, 2013 /PRNewswire/ -- Mesenchymal stem cells, or MSCs, are multipotent stromal cells that can differentiate into a variety of cell types. MSCs have been widely applied in treatments for various diseases and proved to be effective. It can encompass multipotent cells derived from both marrow tissue and other non-marrow tissues. Previously, the application of mesenchymal stem cells resourced from bone marrow was limited due to the complicated procedure and technique; however, things change now!
Adipose tissue is one of the richest sources of MSCs. In ReLife International Medical Center, we derive adipose-derived stem cells that exist in adipose tissue via liposuction. Compared to bone marrow resource mesenchymal stem cells,
In ReLife, we derive the MSCs from patient's own body via liposuction, which avoids the immunity attack and painful procedure. Combining the adipose-derived stem cells with gene therapy and Traditional Chinese Medicine, the innovative stem cell-based gene therapy is able to effectively treat many diseases that do not response well to conventional methods.
1. De Ugarte DA, Morizono K. Comparison of multilineage cells from human adipose tissue and bone marrow. Cells Tissue Organs 2003;174:101-109
2. Cu L, Yin S, Yang P, et al. Human adipose derived stem cells suppress lymphocyte proliferation induced by cellular or non specific mitogenic stimuli. Natlmed J China 2005;85(27):1890-1894
3. Safford KM, Hicok KC, Safford SD,et al.Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002; 294(2):371-379
©2012 PR Newswire. All Rights Reserved.
WISTV License Subsidiary, LCC
1111 Bull St.